Applications published 27 June 2007

Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants
Boehringer Ingelheim International 1799191*

Compsns and methods for treating excessive bleeding
Provonost 1799192*

Encapsulating plant extracts adsorbed and/or absorbed in precipitated silica
Axiss France 1799193*

A new class of surfactant-like materials comprising vitamin E TPGS and a water soluble polymer
Boehringer Ingelheim Pharmaceuticals 1799194*

Granules comprising paracetamol, an NSAID and a sugar alcohol made by melt extrusion
Reckitt Benckiser Healthcare 1799195*

Controlled release pharmaceutical compsns comprising a fumaric acid ester
Aditech Pharma 1799196*

Highly-aqueous non-respirable aerosols containing biologically active ingredients method of making and device therefor
Battelle Memorial Institute 1799197*

Methods and compsns for the treatment of diseases characterised by pathological calcification
Nanobac Life Sciences 1799198*

Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
Novartis; Novartis-Pharma 1799199*

Polyamine analogues as therapeutic agents for ocular diseases
Cellgate; The Johns Hopkins University 1799200*

4-hydroxy tamoxifen gel formulations
Laboratoires Besins International 1799201*

Therapeutic agent useful for the treatment of plasma cell neoplasias
Euron 1799202*

Agent for prophylaxis or treatment of metabolic syndrome
Takeda Pharmaceutical Company 1799203*

Compsn containing omega-3 fatty acids and omega-6 fatty acids
Dr Gerhard Mann chem. -pharma. Fabrik 1799204*

Medicaments for inhalation comprising PDE IV inhibitors and enantiomerically pure glycopyrrolate salts
Boehringer Ingelheim International 1799205*

Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2B or A3 receptor
Novartis 1799206*

Pyrazole or triazole compounds and their use for the medicament for treating somatic mutation-related diseases
PTC Therapeutics 1799207*

Heterocyclic aromatic compounds useful as growth hormone secretagogues
Bristol-Myers Squibb 1799208*

Compsns containing piperacillin, tazobactam and a amino carboxilic acid in a sodium lactate diluent
Wyeth 1799209*

A guanylate cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary asoconstriction
Bayer HealthCare 1799210*

Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
Altana Pharma 1799211*

Compounds for nonsense suppression, and methods for their use
PTC Therapeutics 1799212*

Novel curcumin analogues and uses thereof
The University of North Carolina at Chapel Hill 1799213*

Non-peptide bradykinin antagonists and pharmaceutical compsns therefrom
Instituto Luso Farmaco d'Italia 1799214*

Chemokine-binding heterocyclic compound salts, and methods of use thereof
Anormed 1799215*

Tadalafil crystal forms and processes for preparing them
Teva Pharmaceutical Industries 1799216*

Compounds and methods of treating insulin resistance and cardiomyopathy
Forbes Medi-Tech (Research) 1799217*

HCV inhibiting bi-cyclic pyrimidines
Tibotec Pharmaceuticals 1799218*

Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain
Laboratoires del Dr Esteve 1799219*

Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain
Laboratoires del Dr Esteve 1799220*

Method of preventing and treating airway remodelling and pulmonary inflammation using A2B adenosine receptor antagonists
CV Therapeutics 1799221*

Compounds that inhibit replication of human immunodeficiency virus
Tripep 1799222*

Arylthiobenzylpiperadine derivatives
H Lundbeck 1799223*

Memantine for the treatment of childhood behavioural disorders
Merz Pharma 1799224*

Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
Centre National de la Recherche Scientifique; Universite de Poitiers 1799225*

Use of midostaurin for treating stromal tumours
Novartis 1799226*

Therapeutic agents targeting the NC CA-ATP channel and methods of use thereof
University of Maryland, Baltimore; Department of Veterans Affairs 1799227*

Topical compsns containing phosphorylated polyphenols
Ajinomoto Omnichem; Estee Lauder Coordination Centre 1799228*

Pulmonary administration of an antithrombitic compound
NV Organon 1799229*

Purine and purimidine CDK inhibitors and their use for the treatment of autoimmune diseases
Cyclacel 1799230*

Use of cyclodextrin for treatment of bronchial inflammatory diseases
Universite de LiEge 1799231*

Self-gelling alginate systems and uses thereof
FMC Biopolymer 1799232*

Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilising protein
William Marsh Rice University; The Children's Hospital of Philadelphia 1799234*

Fetal skin cell protein compsns for the treatment of skin conditions, disorders or diseases and methods of making and using the same
Neocutis 1799235*

Liver stromal cells for prevention and treatment of immune responses in transplantation
Cognate Therapeutics 1799236*

Ointment for joining broken and fractured bones
Nagpure, Vilas Akushrao 1799237*

Treatment of bone disorders with skeletal anabolic drugs
Osteotrophin 1799240*

Combination therapy for the treatment of obesity
Merck & Co 1799241*

G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
The Regents of the University of California; The University of Alabama Research Foundation 1799242*

Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
University of Rochester 1799243*

Furin Inhibitors
Smith, Judith 1799244*

Use of angiotensis-(1,-7) for preventing and/or reducing the formation of neointima
Stichting Klinische Farmacologie Groningen 1799245*

Chimeric protein
amoretti 1799246*

Method for diagnosing and treating bone-related diseases
AIC 1799247*